Qatar Investment Authority logo

Qatar Investment Authority

Asia, Ad Dawhah, Qatar, Doha

Description

The Qatar Investment Authority (QIA) is the sovereign wealth fund of Qatar, established in 2005 to strengthen the country's economy by diversifying its investments globally and generating long-term returns for future generations. With assets under management estimated to be around $500 billion as of early 2024, QIA is one of the world's largest and most influential institutional investors. Its mandate is to protect and grow Qatar's financial assets, moving beyond reliance on hydrocarbon revenues.

Investor Profile

Qatar Investment Authority has backed more than 84 startups, with 19 new investments in the last 12 months alone. The firm has led 29 rounds, about 35% of its total and boasts 33 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series C, Series B, Series D rounds (top funding stages).
  • Majority of deals are located in United States, India, United Kingdom.
  • Strong thematic focus on Biotechnology, Health Care, Medical.
  • Led 9 rounds in the past year.
  • Typical check size: $100M – $5000M.

Stage Focus

  • Series C (19%)
  • Series B (15%)
  • Series D (14%)
  • Private Equity (14%)
  • Series Unknown (12%)
  • Series E (5%)
  • Series J (4%)
  • Series G (4%)
  • Series F (4%)
  • Series I (2%)

Country Focus

  • United States (56%)
  • India (11%)
  • United Kingdom (10%)
  • Germany (7%)
  • China (6%)
  • Switzerland (4%)
  • Singapore (2%)
  • France (1%)
  • South Korea (1%)
  • Turkey (1%)

Industry Focus

  • Biotechnology
  • Health Care
  • Medical
  • Artificial Intelligence (Ai)
  • Therapeutics
  • Biopharma
  • Machine Learning
  • Life Science
  • Software
  • Financial Services
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Qatar Investment Authority frequently co-invest with?

CA
North America, Massachusetts, United States, Boston
Co-Investments: 7
Alexandria Venture Investments
North America, California, United States, Pasadena
Co-Investments: 9
SoftBank Vision Fund
Europe, England, United Kingdom, London
Co-Investments: 7
GIC
Asia, Central Region, Singapore, Singapore
Co-Investments: 6
RA Capital Management
North America, Massachusetts, United States, Boston
Co-Investments: 8
Temasek Holdings
Asia, Central Region, Singapore, Singapore
Co-Investments: 7
BlackRock
North America, New York, United States, New York
Co-Investments: 7
Andreessen Horowitz
North America, California, United States, Menlo Park
Co-Investments: 7
Tiger Global Management
North America, New York, United States, New York
Co-Investments: 8
Fidelity
North America, Massachusetts, United States, Boston
Co-Investments: 13

Which angels does Qatar Investment Authority often collaborate with?

JA
North America, California, United States, San Francisco
Shared Deals: 1
Razmig Hovaghimian
North America, Quintana Roo, Mexico, San Francisco
Shared Deals: 1
HM
North America, New Providence, Bahamas, Nassau
Shared Deals: 1
CF
North America, Illinois, United States, Chicago
Shared Deals: 1
SS
Europe, England, United Kingdom, London
Shared Deals: 1
SP
North America, California, United States, San Francisco
Shared Deals: 1

What are some of recent deals done by Qatar Investment Authority?

ARTBIO

Cambridge, Massachusetts, United States

ARTBIO is a clinical-stage radiopharmaceutical biotechnology business that is working to create a new class of alpha radioligand medicines.

BiotechnologyHealth CareHospitalMedicalMedical DevicePharmaceutical
Series BJul 29, 2025
Amount Raised: $132,000,000
Kardium

Burnaby, British Columbia, Canada

Kardium is a medical solutions company that develops a globe pulsed field system for the diagnosis and treatment of atrial fibrillation.

HardwareHealth DiagnosticsManufacturingMedicalMedical Device
Private EquityJul 2, 2025
Amount Raised: $249,198,899
Applied Intuition

Mountain View, California, United States

Applied Intuition provides software infrastructure to safely develop, test, and deploy autonomous vehicles
 at scale.

Artificial Intelligence (AI)Autonomous VehiclesEnterprise SoftwareInfrastructureSoftware
Series FJun 17, 2025
Amount Raised: $600,000,000
GlycoEra

Schlieren, Zurich, Switzerland

GlycoEra is a biotechnology research company that produces extracellular protein degraders for the treatment of autoimmune diseases.

BiotechnologyHealth CareMedical
Series BMay 27, 2025
Amount Raised: $130,000,000
Neuralink

Fremont, California, United States

Neuralink is a neurotechnology company that focuses on developing brain-computer interfaces designed to treat neurological disorders.

BiotechnologyMedicalNeuroscienceRobotics
Series EMay 27, 2025
Amount Raised: $650,000,000
China Asset Management

Beijing, Beijing, China

China Asset Management is a fund management company in China that focuses on mutual funds assets under management.

Asset ManagementFinanceFinancial Services
Secondary MarketMay 22, 2025
Amount Raised: $3,303,583
Rebel Foods

Mumbai, Maharashtra, India

Rebel Foods operates multiple food brands using culinary innovation and technology.

E-CommerceFood DeliveryFood ProcessingMobile Apps
Series UnknownApr 22, 2025
Amount Raised: $25,000,000
Lomond Therapeutics

San Diego, California, United States

Lomond Therapeutics creates pharmacological platforms that target escape mutations.

BiopharmaBiotechnologyHealth CareMedical
Series UnknownMar 27, 2025
Amount Raised: $20,000,000
Supira Medical

Los Gatos, California, United States

Supira Medical is a clinical-stage company that develops catheter-based circulatory support devices for patients with heart conditions.

Health CareMedicalMedical Device
Series EMar 26, 2025
Amount Raised: $120,000,000
Arbor Biotechnologies

Cambridge, Massachusetts, United States

Arbor Biotechnologies is a biotechnology company specializing in next-generation gene editing therapeutics to treat genetic diseases.

BiopharmaBiotechnologyLife Science
Series CMar 18, 2025
Amount Raised: $73,900,000